If confirmed by the Senate, Heidi Overton, MD, PhD, would replace Marty Makary, MD, who resigned in May. Overton, who is associated with the America First Policy Institute, is an outspoken opponent of the abortion drug mifepristone.

Medicare Advantage plans were the least likely to deny standard requests but still did so about 12% of the time. Medicaid managed care insurers rejected standard prior authorizations 14% of the time on average. KFF used 2025 payer data on 71 million Americans for its analysis.

While LifeStance Health maintains it did not knowingly do anything wrong and is committed to the privacy of its patients, it has agreed to make sure that no third-party tracking technologies are running on its website.

The prosecution has until Oct. 9 to respond to the defense's motion to dismiss. Attorneys representing Luigi Mangione, the man who confessed in federal court to killing UnitedHealthcare CEO Brian Thompson, argue that a second trial would violate their client’s civil rights.

A U.S. District Court judge ruled that the states were unable to show they would be irreparably harmed by complying with the policy, as the Centers for Medicare & Medicaid Services is covering 90% of the associated costs.

Was Dr. Anthony Fauci a lighthouse keeper ably guiding America through a dense fog, albeit by contingent directions and course corrections? Or was he a power-mad scientist cynically covering his tracks—heedless of the resulting population-level harms unfolding day by day—after helping start the crisis in the first place? 

The former “Shark Tank” panelist and current co-owner of Cost Plus Drugs on Aug. 19 defended members of the specialty against claims they will be replaced by artificial intelligence. 

Remote monitoring devices are gaining popularity in the fields of hypertension and heart failure, but many health systems still struggle to get data into their EHR.